Clinical effects of the CD13/CD33 ratio on the prognosis of myelodysplastic syndrome treated with azacitidine. Issue 5 (15th April 2020)

Record Type:: Journal Article
Title:: Clinical effects of the CD13/CD33 ratio on the prognosis of myelodysplastic syndrome treated with azacitidine. Issue 5 (15th April 2020)
Main Title:: Clinical effects of the CD13/CD33 ratio on the prognosis of myelodysplastic syndrome treated with azacitidine
Authors:: Oka, Satoko
Ono, Kazuo
Nohgawa, Masaharu
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 61:Issue 5(2020)
Journal:: Leukemia & lymphoma
Issue:: Volume 61:Issue 5(2020)
Issue Display:: Volume 61, Issue 5 (2020)
Year:: 2020
Volume:: 61
Issue:: 5
Issue Sort Value:: 2020-0061-0005-0000
Page Start:: 1250
Page End:: 1253
Publication Date:: 2020-04-15
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2020.1711903 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 13603.xml